Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1139-1145

  Takahashi, Nobuyasu ^a   Aoyama, Fumiyo ^a   Hiyoshi, Masahide ^a   Kataoka, Hiroaki ^a   Sawaguchi, Akira ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

fetoprotein; Cell line; Glypican 3; Hepatoid adenocarcinoma

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; FLUOROURACIL; GEMCITABINE; GLYCOGEN; GLYPICAN; GPC3 PROTEIN, HUMAN; MESSENGER RNA;

ADENOCARCINOMA; AGED; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BILE DUCT NEOPLASMS; BIOSYNTHESIS; CANCER TRANSPLANTATION; CYTOLOGY; DRUG RESISTANCE; GASTROINTESTINAL NEOPLASMS; GENETICS; HUMAN; IMMUNOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; VATER PAPILLA; XENOGRAFT;

ADENOCARCINOMA; AGED; ALPHA-FETOPROTEINS; AMPULLA OF VATER; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; GLYCOGEN; GLYPICANS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84894469340     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2282     Document Type: Article

References (31)

1. Bourreille J, Metayer P, Sauger F, Matray F and Fondimare A: Existence of alpha fetoprotein during gastric-origin secondary cancer of the liver. Presse Med 78: 1277-1278, 1970 (In French).
2. Ishikura H, Kirimoto K, Shamoto M, et al: Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 58: 119-126, 1986.
3. Lattes C, Carella R, Faggioli S, Gabusi E and Grigioni WF: Hepatoid adenocarcinoma of the rectum arising in ulcerative colitis: report of a case. Dis Colon Rectum 43: 105-108, 2000.
4. Paner GP, Thompson KS and Reyes CV: Hepatoid carcinoma of the pancreas. Cancer 88: 1582-1589, 2000.
5. Arnould L, Drouot F, Fargeot P, et al: Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor. Am J Surg Pathol 21: 1113-1118, 1997.
6. Motoyama T, Higuchi M and Taguchi J: Combined choriocarcinoma, hepatoid adenocarcinoma, small cell carcinoma and tubular adenocarcinoma in the oesophagus. Virchows Arch 427: 451-454, 1995.
7. Gardiner GW, Lajoie G and Keith R: Hepatoid adenocarcinoma of the papilla of Vater. Histopathology 20: 541-544, 1992.
8. Sinard J, Macleay L Jr and Melamed J: Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type. Cancer 73: 1919-1925, 1994.
9. Ishikura H, Ishiguro T, Enatsu C, et al: Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment. Cancer 67: 3051-3056, 1991.
10. Devouassoux-Shisheboran M, Schammel DP and Tavassoli FA: Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features. Histopathology 34: 462-469, 1999.
11. Toyoda H, Hirai T and Ishii E: Alpha-fetoprotein producing uterine corpus carcinoma: a hepatoid adenocarcinoma of the endometrium. Pathol Int 50: 847-852, 2000.
12. Shintaku M, Kariya M, Shime H and Ishikura H: Adenocarcinoma of the uterine cervix with choriocarcinomatous and hepatoid differentiation: report of a case. Int J Gynecol Pathol 19: 174-178, 2000.
13. Kono K, Amemiya H, Sekikawa T, et al: Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19: 359-365, 2002.
14. Takahashi Y, Mai M, Ogino T, Ueda H, Sawaguchi K and Ueno M: Clinicopathological study of AFP producing gastric cancer - significance of AFP in gastric cancer. Nihon Geka Gakkai Zasshi 88: 696-700, 1987 (In Japanese).
15. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD and Nakamura T: Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87: 321-325, 1992.
16. Sekiguchi M, Fujii Y, Saito A, et al: Alpha-fetoprotein-producing gastric carcinoma: biological properties of a cultured cell line. J Gastroenterol 30: 589-598, 1995.
17. Matsuda M, Watanabe A, Sawada H, et al: Establishment of an alpha-fetoprotein-producing cell line derived from gastric cancer. In Vitro Cell Dev Biol Anim 35: 555-557, 1999.
18. Terashima M, Ikeda K, Maesawa C, et al: Establishment of an alpha-fetoprotein-producing gastric cancer cell line in serum-free media. Jpn J Cancer Res 82: 883-885, 1991.
19. Takahashi Y, Ohta T and Mai M: Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody. Oncol Rep 11: 809-813, 2004.
20. +-ATPase in gastric parietal cells. J Histochem Cytochem 52: 77-86, 2004.
21. Sawaguchi A, Aoyama F, Ide S, Goto Y and Suganuma T: A new device for high-pressure freezing of cultured cell monolayer using 10-micron-thin stainless discs as both culture plate and specimen carrier. J Electron Micros 57: 203-206, 2008.
22. Sawaguchi A, Aoyama F, Ide S and Suganuma T: Capsule-supporting ring: a new device for resin embedding of glass-mounted specimens. J Microsc 234: 113-117, 2009.
23. Aoyama F, Sawaguchi A, Ide S, Kitamura K and Suganuma T: Exfoliation of gastric pit-parietal cells into the gastric lumen associated with a stimulation of isolated rat gastric mucosa in vitro: a morphological study by the application of cryotechniques. Histochem Cell Biol 129: 785-793, 2008.
24. Terracciano LM, Glatz K, Mhawech P, et al: Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol 27: 1302-1312, 2003.
25. Muehlemann M, Miller KD, Dauphinee M and Mizejewski GJ: Review of growth inhibitory peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer Metastasis Rev 24: 441-467, 2005.
26. Nagai E, Ueyama T, Yao T and Tsuneyoshi M: Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 72: 1827-1835, 1993.
27. Yorita K, Takahashi N, Takai H, et al: Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma. Liver Int 31: 120-131, 2011.
28. Hishinuma M, Ohashi KI, Yamauchi N, et al: Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma. Histopathology 49: 479-486, 2006.
29. Morford LA, Davis C, Jin L, Dobierzewska A, Peterson ML and Spear BT: The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2. Hepatology 46: 1541-1547, 2007.
30. Nakano K, Orita T, Nezu J, et al: Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem Biophys Res Commun 378: 279-284, 2009.
31. Ishiguro T, Sugimoto M, Kinoshita Y, et al: Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res 68: 9832-9838, 2008.